1. Home
  2. ICMB vs MDXH Comparison

ICMB vs MDXH Comparison

Compare ICMB & MDXH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Investcorp Credit Management BDC Inc.

ICMB

Investcorp Credit Management BDC Inc.

BUY

Current Price

$0.70

Market Cap

17.2M

Sector

Finance

ML Signal

BUY

Logo MDxHealth SA

MDXH

MDxHealth SA

HOLD

Current Price

$0.18

Market Cap

18.5M

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
ICMB
MDXH
Founded
2013
2003
Country
United States
Belgium
Employees
N/A
N/A
Industry
Finance: Consumer Services
Sector
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
17.2M
18.5M
IPO Year
2013
2021

Fundamental Metrics

Financial Performance
Metric
ICMB
MDXH
Price
$0.70
$0.18
Analyst Decision
Buy
Analyst Count
0
6
Target Price
N/A
★ $1.13
AVG Volume (30 Days)
32.3K
★ 1.4M
Earning Date
11-11-2026
11-12-2026
Dividend Yield
★ 21.53%
N/A
EPS Growth
N/A
★ N/A
EPS
N/A
★ N/A
Revenue
N/A
N/A
Revenue This Year
$5.32
$5.10
Revenue Next Year
N/A
$13.22
P/E Ratio
★ N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.62
$0.17
52 Week High
$3.12
$5.33

Technical Indicators

Market Signals
Indicator
ICMB
MDXH
Relative Strength Index (RSI) 44.16 23.28
Support Level $0.65 N/A
Resistance Level $0.88 $0.66
Average True Range (ATR) 0.06 0.05
MACD 0.00 -0.04
Stochastic Oscillator 54.31 2.60

Price Performance

Historical Comparison
ICMB
MDXH

About ICMB Investcorp Credit Management BDC Inc.

Investcorp Credit Management BDC Inc is an externally managed, non-diversified closed-end management investment firm that has elected to be regulated as a business development company (BDC). The investment objective of the company is to maximize total return to stockholders in the form of current income and capital appreciation by investing in debt and related equity of privately held lower middle-market companies. The company principally invests in the debt of middle-market companies, which it defines as those companies that have an enterprise value.

About MDXH MDxHealth SA

MDxHealth SA is a multinational healthcare company that provides actionable molecular diagnostic information to personalize the diagnosis and treatment of cancer. Its tests are based on proprietary genomic, epigenetic, and other molecular technologies and assist physicians with the diagnosis of urologic cancers, the prognosis of recurrence risk, and the prediction of response to a specific therapy. It derives revenues from clinical laboratory service testing or the out-licensing of the company's patented DNA methylation platform and biomarkers. Geographically, it derives revenue from the United States of America (USA) and Europe.

Share on Social Networks: